Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease
Department of Respiratory Medicine, Aarhus County Hospital, Aarhus, Denmark.
Region Östergötland, Heart and Medicine Center, Allergy Center. Linköping University, Department of Clinical and Experimental Medicine, Division of Neuro and Inflammation Science. Linköping University, Faculty of Medicine and Health Sciences. Respiratory System Drug Committee at Region Östergötland, Linköping, Sweden.ORCID iD: 0000-0003-1745-6816
Department of Respiratory Medicine and Allergology, Institute of Clinical Science, Lund University, Lund, Sweden.
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Denmark;Department of Medicine, National Hospital, Torshavn, Faroe Islands.
Show others and affiliations
2015 (English)In: European clinical respiratory journal, ISSN 2001-8525, Vol. 2, 1-8 p., 29445Article, review/survey (Refereed) Published
Abstract [en]

The effective self-management of obstructive lung disease is dependent upon the patient achieving good inhaler technique. However, many current inhalers are complicated to use, which may lead to handling difficulties. These difficulties can cause clinically relevant errors, whereby pharmacotherapy fails to achieve adequate lung deposition and therapeutic effect. In this report, the potential of novel inhaler devices to overcome unmet needs in the management of obstructive lung disease is considered by a panel of Nordic experts. The panel concludes that innovative inhalers can contribute to good disease management and better use of healthcare resources.

Place, publisher, year, edition, pages
2015. Vol. 2, 1-8 p., 29445
Keyword [en]
COPD; access; asthma; choice; cost; dry powder inhaler; economic; innovation; medication errors; metered dose inhaler; obstructive lung disease; outcome; patient compliance; patient preference; price; reimbursement; substitution
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:liu:diva-126609DOI: 10.3402/ecrj.v2.29445PubMedID: 26689215OAI: oai:DiVA.org:liu-126609DiVA: diva2:915868
Available from: 2016-03-31 Created: 2016-03-31 Last updated: 2017-05-02

Open Access in DiVA

fulltext(470 kB)114 downloads
File information
File name FULLTEXT01.pdfFile size 470 kBChecksum SHA-512
addb674fa31beaa298123272fc69669c617ee10ded7a0c363c198600e33ac9c55875ae445f957e14d2e6f79df3fbbaaedf7c5c33897072c82721b4d22e0d25d0
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ahlbeck, LarsBjermer, LeifMortensen, JannØstrem, AndersPasternack, IrisSafioti, GuilhermeTorvinen, Saku
By organisation
Allergy CenterDivision of Neuro and Inflammation ScienceFaculty of Medicine and Health Sciences
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar
Total: 114 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 157 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf